Transcript
Page 1: Swansea Medical School: driving industry and academic ... · Swansea Medical School: driving industry and academic collaborations ACNM •€3.3 of seed corn funding from WEFO for

Swansea Medical School: driving industry and academic collaborations

ACNM• €3.3 of seed corn funding from WEFO for

Industry-Academia projects intended to lead to lasting relationships

• Involves Swansea Medical School, College of Engineering, Centre of Nanohealth, Welsh Centre of Painting and Coating (WCPC) and Cardiff University

• 23 academics onboard with supporting research, administrative and business engagement staff

• Cost to Companies involved with ACNM projects = £ 0, (companies contribute through in-kind funding)

Page 2: Swansea Medical School: driving industry and academic ... · Swansea Medical School: driving industry and academic collaborations ACNM •€3.3 of seed corn funding from WEFO for

Semiconductors

Welsh Centre for Printing and

Coating

Biomedical/ Health Sciences

ACNM and what it offers industry

David HowardResearch Officer for ACNMEmail: [email protected]:01792 606883

Reproductive Biology and Gynaecological Oncology

Page 3: Swansea Medical School: driving industry and academic ... · Swansea Medical School: driving industry and academic collaborations ACNM •€3.3 of seed corn funding from WEFO for

Swansea University track record supporting industry in Wales

Companies already supported via ACNM grant:• Midatech Pharma,• Cellesce,• Telonostix,• Cupid• Rutherford Health• SPTS• Tinmasters• NWF• CSC• Stratium

2 years still to run…

Page 4: Swansea Medical School: driving industry and academic ... · Swansea Medical School: driving industry and academic collaborations ACNM •€3.3 of seed corn funding from WEFO for

Cellesce Ltd. - ACNM

Image from https://cellesce.com/

IN Cell Analyser 6000, Swansea Uni.

Background:• Cellesce has developed a bioprocess to grow the organoids at scale to make

them accessible to high-throughput applications to position organoid technology as a cost effective and accurate tool in drug discovery and other applications.

Project:• Cellesce is providing access to patient derived colon cancer organoids in order

to: 1) develop staining and high-content imaging protocol for 3D organoids & 2) develop tools to analyse large 3D image sets and extract relevant biological information

Outputs for Cellesce and Swansea University:• Organoid screening protocols for drug development purposes• 3D imaging methodologies for answering biological questions• Methodologies that can be translated to other 3D tumour modelsOutputs for Wales Biomedical Industry:• Job creation• Improving local skills base• Expanding products and processes developed in Wales leading to increased

competitiveness in a global market.